From F00 l. I think they need to do some more research - nothing about Fragile X, TBI, etc.
2 growing biotech stocks for your portfolio in 2015
By now investors will have come to terms with the fact that in 2014 the gains from the S&P/ASX 200 were nothing short of lacklustre.
Despite the flat result and the less-than-rosy economic outlook for 2015 there are always ‘gems’ to be found on the stock market.
Neuren Pharmaceuticals Ltd
Having gained close to 50% in the last year, Neuren currently trades at 15.5 cents and with a market capitalisation of approximately $250 million. Neuren is hoping to develop a drug to treat Rett syndrome – a disease for which there is currently no cure.
Ready set blast off, page-21
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$16.57 |
Change
2.170(15.1%) |
Mkt cap ! $2.117B | |||
| Open | High | Low | Value | Volume |
| $14.85 | $16.67 | $14.60 | $24.77M | 1.544M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1500 | $16.52 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $16.57 | 1717 | 1 |
View Market Depth
| Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
| NEU (ASX) Chart |